Baicalein inhibits the invasion and metastatic capabilities of hepatocellular carcinoma cells via down-regulation of the ERK pathway. [electronic resource]
Producer: 20140615Description: e72927 p. digitalISSN:- 1932-6203
- Animals
- Antineoplastic Agents -- administration & dosage
- Antioxidants -- administration & dosage
- Carcinoma, Hepatocellular -- drug therapy
- Cell Line, Tumor
- Cell Movement -- drug effects
- Cell Proliferation -- drug effects
- Disease Models, Animal
- Dose-Response Relationship, Drug
- Enzyme Activation -- drug effects
- Flavanones -- administration & dosage
- Gene Expression Regulation, Neoplastic -- drug effects
- Humans
- Liver Neoplasms -- drug therapy
- MAP Kinase Signaling System -- drug effects
- Male
- Matrix Metalloproteinase 2 -- genetics
- Matrix Metalloproteinase 9 -- genetics
- Mice
- Neoplasm Invasiveness
- Neoplasm Metastasis
- Tissue Inhibitor of Metalloproteinase-1 -- genetics
- Tissue Inhibitor of Metalloproteinase-2 -- genetics
- Transcription, Genetic
- Urokinase-Type Plasminogen Activator -- genetics
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.